Table 1 Clinicopathological characteristics of patients
N (%) | |
|---|---|
GENDER | |
M | 24 (88.9) |
F | 3 (11.1) |
AGE (median - range) | 70 (44–86) |
METASTATIC AT DIAGNOSIS | 4 (14.8) |
CONCURRENT BLADDER CANCER | 8 (29.6) |
METACHRONOUS TUMOURS IN LOWER URINARY TRACT | 19 (70.4) |
LOCATION | |
Pelvis | 16 (59.3) |
Urether | 11 (40.7) |
SURGERY | 26 (96.3) |
PATHOLOGICAL T STAGE | |
Ta | 1 (3.7) |
T1 | 10 (37.0) |
T2 | 5 (18.5) |
T3 | 11 (40.7) |
PATHOLOGICAL N STAGE | |
N0 | 1 (3.7) |
N1 | 1 (3.7) |
NX | 25 (92.6) |
GRADE | |
High | 19 (70.4) |
Low | 8 (29.6) |
LYMPHOVASCULAR INVASION | |
Yes | 4 (14.8) |
No | 23 (85.2) |
HISTOLOGY | |
Urothelial | 24 (88.9) |
Squamous cell carcinoma | 3 (11.1) |
SMOKING | 22 (81.5) |
PRESENCE OF A SECOND PRIMARY CANCER | 5 (18.5) |
FAMILY HISTORY OF CANCER | 5 (18.5) |
PROFESSIONAL RISK FACTOR EXPOSURE | 12 (44.4) |
ADJUVANT CHEMOTHERAPY | 4 (14.8) |